ABCIXIMAB: 322 Adverse Event Reports & Safety Profile
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
322
Total FAERS Reports
79 (24.5%)
Deaths Reported
100
Hospitalizations
322
As Primary/Secondary Suspect
45
Life-Threatening
4
Disabilities
Prescription
Status
FDA Application: 103575 ·
First Report: 199602 · Latest Report: 20211019
What Are the Most Common ABCIXIMAB Side Effects?
#1 Most Reported
Thrombocytopenia
71 reports (22.0%)
#2 Most Reported
Off label use
35 reports (10.9%)
#3 Most Reported
Haemorrhage
29 reports (9.0%)
All ABCIXIMAB Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Thrombocytopenia | 71 | 22.1% | 2 | 34 |
| Off label use | 35 | 10.9% | 3 | 4 |
| Haemorrhage | 29 | 9.0% | 6 | 7 |
| Incorrect route of drug administration | 28 | 8.7% | 0 | 1 |
| Haemorrhage intracranial | 23 | 7.1% | 8 | 5 |
| Anaemia | 22 | 6.8% | 2 | 17 |
| Drug interaction | 17 | 5.3% | 7 | 7 |
| Product use issue | 17 | 5.3% | 1 | 1 |
| Vascular stent thrombosis | 17 | 5.3% | 2 | 5 |
| Cerebral haemorrhage | 15 | 4.7% | 4 | 3 |
| Petechiae | 15 | 4.7% | 0 | 13 |
| Haemorrhagic transformation stroke | 14 | 4.4% | 12 | 3 |
| Labelled drug-drug interaction medication error | 14 | 4.4% | 0 | 11 |
| Pulmonary haemorrhage | 14 | 4.4% | 13 | 1 |
| Hypotension | 13 | 4.0% | 2 | 10 |
| Product use in unapproved indication | 13 | 4.0% | 0 | 2 |
| Gastrointestinal haemorrhage | 11 | 3.4% | 7 | 4 |
| Gingival bleeding | 11 | 3.4% | 0 | 8 |
| Drug ineffective | 10 | 3.1% | 1 | 3 |
| Ecchymosis | 10 | 3.1% | 0 | 10 |
Who Reports ABCIXIMAB Side Effects? Age & Gender Data
Gender: 33.1% female, 66.9% male. Average age: 60.9 years. Most reports from: US. View detailed demographics →
Is ABCIXIMAB Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2002 | 1 | 0 | 0 |
| 2003 | 1 | 1 | 0 |
| 2004 | 8 | 7 | 1 |
| 2005 | 18 | 14 | 6 |
| 2006 | 2 | 1 | 1 |
| 2011 | 3 | 0 | 3 |
| 2012 | 1 | 1 | 1 |
| 2013 | 4 | 0 | 2 |
| 2014 | 23 | 8 | 7 |
| 2015 | 12 | 2 | 5 |
| 2016 | 10 | 0 | 7 |
| 2017 | 17 | 0 | 11 |
| 2018 | 12 | 2 | 5 |
| 2019 | 1 | 1 | 0 |
| 2021 | 1 | 0 | 0 |
What Is ABCIXIMAB Used For?
| Indication | Reports |
|---|---|
| Product used for unknown indication | 71 |
| Percutaneous coronary intervention | 49 |
| Acute myocardial infarction | 30 |
| Ischaemic stroke | 19 |
| Acute coronary syndrome | 18 |
| Thrombosis | 17 |
| Antiplatelet therapy | 13 |
| Stent placement | 12 |
| Myocardial infarction | 11 |
| Catheter placement | 8 |
ABCIXIMAB vs Alternatives: Which Is Safer?
ABCIXIMAB vs ABEMACICLIB
ABCIXIMAB vs ABILIFY
ABCIXIMAB vs ABIRATERONE
ABCIXIMAB vs ABIRATERONE\ABIRATERONE
ABCIXIMAB vs ABOBOTULINUMTOXINA
ABCIXIMAB vs ABRAXANE
ABCIXIMAB vs ABROCITINIB
ABCIXIMAB vs ACALABRUTINIB
ABCIXIMAB vs ACAMPROSATE
ABCIXIMAB vs ACARBOSE
Official FDA Label for ABCIXIMAB
Official prescribing information from the FDA-approved drug label.